Description

Acro-Trestolone (MENT) 50mg/ml

Acro® – Trestolone (MENT), also known as methylnortestosterone acetate or trestolone acetate, is a synthetic anabolic-androgenic steroid derived from the nandrolone family.

Trestolone was originally developed as a potential androgen replacement compound. It has been studied for possible use in conditions such as androgen deficiency, male contraception research, bone density loss, muscle wasting (cachexia and sarcopenia), hypogonadism, and other hormone-related disorders. It has also been explored in research related to prostate health and androgen replacement therapy.

How it works

Trestolone (MENT) works by strongly suppressing gonadotropin release, which reduces the body’s natural production of testosterone and sperm. Despite this suppression, it acts as a powerful androgen receptor agonist and can mimic many effects of testosterone in the body. Because of its potency, it produces strong anabolic and androgenic activity even at relatively low doses.

Proper Use and Dosage

Acro-Trestolone (MENT) 50mg/ml is typically administered via intramuscular injection. Dosage varies depending on experience, tolerance, and goals. Common use ranges from 50–100mg every other day. Beginners are usually advised to start at lower doses to assess response, while more experienced users may adjust cautiously. Cycle lengths are generally kept short, around 6–8 weeks, due to its strong suppressive effects. Post-cycle therapy (PCT) is commonly used to help restore natural hormonal balance after use. Injection site rotation and proper monitoring are also recommended.

Benefits

Trestolone is known for rapid increases in strength and muscle mass. Because of its strong androgenic activity, it can produce noticeable improvements in physical performance and body composition in a short period of time.

Side Effects

Common side effects may include water retention, acne, increased blood pressure, and hair loss. It can significantly suppress natural testosterone production, which may lead to testicular atrophy and estrogen-related effects such as gynecomastia. Other possible effects include mood changes and increased cardiovascular strain. Proper monitoring and post-cycle therapy are often considered important when using such compounds.